Designed for diabetic, kidney-sensitive, and metabolic-risk populations. Built for hospitals, government programs, institutional nutrition, and large-scale food & beverage reformulation.
SAFE SUGAR™ is a very-low-glycemic functional sugar ingredient developed in the United States for organizations that must manage glycemic exposure without giving up taste, familiarity, or large-scale practicality.
It is positioned not as a lifestyle retail product, but as a health-aligned ingredient platform for diabetic nutrition, hospital and clinical meals, government food programs, and serious reformulation initiatives.
Across the GCC, rising rates of diabetes, pre-diabetes, obesity, and metabolic syndrome are putting pressure on healthcare systems, ministries of health, and national budgets. Standard sugar contributes directly to glycemic load, while many artificial sweeteners create concerns around safety, taste, or long-term acceptability.
SAFE SUGAR™ was developed as a third path: a very-low-glycemic functional sugar ingredient designed for populations where glycemic control, kidney awareness, and long-term metabolic resilience are critical priorities.
SAFE SUGAR™ is designed to help reduce glycemic impact compared with regular sugar, supporting populations where blood-sugar exposure and metabolic stress are major concerns.
Developed for everyday use in high-volume environments—hospital kitchens, manufacturing lines, and public-sector programs—while maintaining familiarity and taste.
SAFE SUGAR™ is not presented as a quick-fix consumer product. It is deployed as a disciplined, health-driven ingredient platform through structured partnerships and clearly defined programs.
SAFE SUGAR™ is available to qualified partners through bulk ingredient supply contracts, institutional and distributor partnerships, and territory-based licensing structures with defined volume commitments.
Contract-based volumes and MOQ-aligned shipments for food and beverage manufacturing and institutional use.
Hospital, clinical, and public-sector channels supported by regional distributors and health-positioning support.
For partners with strong institutional access, including volume commitments, disciplined rollout, and coordinated health-impact and branding control.
For ministries, hospital systems, and large organizations, SAFE SUGAR™ can be introduced via structured pilot programs that focus on:
Lathell Nutraceuticals LLC (USA) is currently selecting a limited number of GCC partners with institutional channels, government or healthcare access, or strong reformulation capability to collaborate on SAFE SUGAR™.
Lathell Sancho
Founder & CEO — Lathell Nutraceuticals LLC (USA)
Email: l.sancho@lathellnutraceuticalsllc.com
Phone: +1 (702) 413-4481